Animal study · Aging · 20 Nov 2026
Mice without granzyme K kept more tissue function with age, while the usual age-related inflammation did not fall
Source: Immunity
What the research found
An open-access paper in Immunity, discussed by Fight Aging on 20 November 2026, looks at granzyme K in mice. Granzyme K rose with age inside the T-cell compartment, mostly in conventional long-lived CD8 T cells. Mice born without granzyme K did not show a lower inflammaging signal: serum IL-6, MCP-1, and C3a still rose with age, and immune aging itself did not ease, at rest or after a challenge. What did change was tissue-level wear. The aging serum proteome looked less like leaking intracellular and mitochondrial contents, and less like organ-stress enzymes such as ALT, AST, and ALDOB. The authors read that as granzyme K acting locally in tissues, not as a switch for whole-body inflammation. This is mouse genetics, not a human treatment, and it does not say that blocking granzyme K would be safe. DOI 10.1016/j.immuni.2026.10.013. Not medical advice.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
More aging news
- In mice, raising FGF13 in astrocytes lined up with slower cognitive aging
- A Cambridge review gathers links between reading for pleasure and brain measures, and it does not show that reading prevents Alzheimer's
- In 253 older adults in Japan, a full intrinsic-capacity score lined up with frailty remission, not with staying robust
- In aged rats, Mboat1 lined up with Schwann cell senescence in the peripheral nerve
- A scoping review charted healthy-aging programs for adults with developmental disabilities